Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data. - Wikidata - wikimedia - TriplyDB

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

http://www.wikidata.org/entity/Q30616078

about

The Role of Oxidative Stress-Induced Epigenetic Alterations in Amyloid-β Production in Alzheimer's Disease Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.Vitamin E for Alzheimer's dementia and mild cognitive impairment.Suboptimal Serum α-Tocopherol Concentrations Observed among Younger Adults and Those Depending Exclusively upon Food Sources, NHANES 2003-20061-3 Knowledge and Attitudes in Alzheimer's Disease in a Cohort of Older African Americans and Caucasians.Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidants.Benefits and risks of add-on therapies for Alzheimer's disease.Vitamin E and Alzheimer's Disease-Is It Time for Personalized Medicine?Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications Measuring informed consent capacity in an Alzheimer's disease clinical trial.Long-Chain Metabolites of Vitamin E: Metabolic Activation as a General Concept for Lipid-Soluble Vitamins?Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice.Vitamin E for Alzheimer's dementia and mild cognitive impairment Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease

P2860

Q26778776-1889BF7C-41D5-46D1-A517-C783C097C9AF Q30584897-28CE971A-4FA1-4854-8C80-DFB011E80D74 Q34550138-682C8CE9-4A82-4496-82FB-745D9EC9DBE7 Q35750238-F6DD089F-A936-4812-BA1B-79352579F2DB Q36901953-937D8CA6-A89A-4595-9B56-04F8F2F312C2 Q37225026-A1D50E94-8EB5-4983-BAC5-30F609F6A998 Q38253060-F536EDC2-91E2-40C7-A395-86EA40C540C8 Q38620338-95A7C40D-0D7D-42D5-A185-F39DA7EBB660 Q39411586-B6E47A97-1985-4C0E-B2BC-79AD11668613 Q41141816-A4F85AF3-4F50-4D7F-ADD0-7C09EE3F8BFA Q42656148-CF836EA7-E199-4DBB-B932-79BD982A1452 Q48253329-F5CDAC31-E7F4-42EC-8C44-800FA8039C96 Q55395713-3C7A0A0B-12FB-408C-9286-F748450DF106 Q56092262-DF4DD1C6-7CB4-4294-B86E-7AC2F9763C12 Q57174487-67968A98-072B-4285-B96B-E28713A56EAB

P2860

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

http://www.wikidata.org/entity/Q30616078

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@ast

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@en

type

label

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@ast

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@en

prefLabel

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@ast

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@en

P1433

Q30616078-2291FB9E-7118-4D16-99B2-A0D4FBD52B53

P1476

Q30616078-8AA7F8A9-BF14-451B-A39F-3EACE58E9666

P2093

Q30616078-078FB634-A3FD-42EB-A43B-FC3CA9C293FC

Q30616078-14F9E4E5-1A8B-48A1-8940-4CBCD6CDA339

Q30616078-176313EC-40BA-4C97-8E76-ED4810046B27

Q30616078-1DF73C01-CAA5-4504-B465-92E0DDFE689D

Q30616078-287F7F79-BD4F-4FBB-9338-B3ADE73DA377

Q30616078-2D7025D4-020D-4418-ACDC-628E1004BA30

Q30616078-374E30C2-B501-47BD-A044-DC4F8E36AB74

Q30616078-3CD25A96-5294-4659-A428-3871EB8C3EC9

Q30616078-414D1F55-FE0E-456E-9FF3-E29B65EA688D

Q30616078-5AAB561E-094E-4B11-B553-8F600415BF4D

P2860

Q30616078-0281920C-AF5D-4479-8D76-AB10B13E113D

Q30616078-0B1F4B72-345A-443A-B1CA-6E725EBCACA7

Q30616078-0CF64B44-E4DB-4A06-B132-B056B3150D7B

Q30616078-14681CA9-47C5-46AC-8A80-B9255C7E103F

Q30616078-16D3D60E-AEDE-4DEE-83A8-271C7496733B

Q30616078-24229270-1387-4DF0-BF03-BF5C311CA3F4

Q30616078-2438A9B5-6864-4C0C-8A82-598CF3D44DCB

Q30616078-2CE86664-E9ED-40F7-94EE-169E7D41CCEF

Q30616078-49782C13-B28A-45CE-BA1A-E07388846728

Q30616078-4A87F8B0-6E00-4960-95D6-D460F100D003

P304

Q30616078-21021245-114D-4002-AC24-E70CF6819FBC

P31

Q30616078-A777CFB4-DD95-43A0-B73E-E9043EE6F7FD

Q30616078-BA787FC8-2341-4CDC-A920-364BCECCC725

P356

Q30616078-B083F34D-DBFE-4629-86E2-2876F9A43612

P433

Q30616078-C03A4DCE-924F-4077-BBDA-FC5C319AA6DB

P478

Q30616078-29A21791-3C01-477A-8001-0E7E330B495F

P50

Q30616078-6FC175FD-90D3-44A9-961D-BC86E9372CC8

Q30616078-BE6792EF-9D7F-4039-8E06-401B7E7F62FE

P577

Q30616078-D137F638-F97B-4FB2-A642-5316497B2FC7

P698

Q30616078-A2D0EEA7-6DD8-4F2A-BC0C-DB0B2C7DF164

P921

Q30616078-33A6B1FF-AC58-47CE-891A-75C921FFA971

P932

Q30616078-305AE45F-D136-4E92-9D1C-BE2D6F848605

P356

J.JALZ.2013.01.014

P1433

Alzheimer's and Dementia

P1476

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.

@en

P2093

Ana Vidal-Cardona

http://www.w3.org/2001/XMLSchema#string

Angel R Cruz

http://www.w3.org/2001/XMLSchema#string

David J Loreck

http://www.w3.org/2001/XMLSchema#string

George Trapp

http://www.w3.org/2001/XMLSchema#string

Gerard D Schellenberg

http://www.w3.org/2001/XMLSchema#string

Govind Vatassery

http://www.w3.org/2001/XMLSchema#string

J Riley McCarten

http://www.w3.org/2001/XMLSchema#string

Jacobo E Mintzer

http://www.w3.org/2001/XMLSchema#string

Judith L Heidebrink

http://www.w3.org/2001/XMLSchema#string

Julia E Vertrees

http://www.w3.org/2001/XMLSchema#string

P2860

Cholinesterase inhibitors for Alzheimer's disease

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model.

The role of oxidative stress in Alzheimer disease.

P304

36-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2013.01.014

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Carolyn L Turvey

Catherine Woodman

P577

2013-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23583234

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

4128187

http://www.w3.org/2001/XMLSchema#string